Efficacy of tixagevimab / cilgavimab as pre-exposure prophy-laxis against infection from SARS-CoV-2 and severe COVID-19 among heavily immunocompromised patients: a single-center, prospective, real-world study.

Σύνολο ερευνητικών δεδομένων uoadl:3405734 11 Αναγνώσεις

Μονάδα:
Τμήμα Ιατρικής
Τίτλος:
Efficacy of tixagevimab / cilgavimab as pre-exposure prophy-laxis against infection from SARS-CoV-2 and severe COVID-19 among heavily immunocompromised patients: a single-center, prospective, real-world study.
Γλώσσες Τεκμηρίου:
Αγγλικά
Έτος δημιουργίας:
2024
Συγγραφείς:
Dimitrios Basoulis1*, Elpida Mastrogianni2, Georgios Karamanakos3, Aikaterini Gkoufa1, Vasiliki E. Georgakopou-lou1, Sotiria Makrodimitri1, Maria N. Gamaletsou1, Antonios Markogiannkis4, Nikolaos V. Sipsas1
Λέξεις-κλειδιά:
covid
Κύρια θεματική κατηγορία:
Επιστήμες Υγείας